PCN71 - BUDGET IMPACT ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN BULGARIA

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.153
https://www.valueinhealthjournal.com/article/S1098-3015(18)33453-3/fulltext
Title : PCN71 - BUDGET IMPACT ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN BULGARIA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33453-3&doi=10.1016/j.jval.2018.09.153
First page :
Section Title :
Open access? : No
Section Order : 924
Categories :
Tags :
Regions :
ViH Article Tags :